Engineering a new cancer detection tool

June 8, 2017
cancer
Killer T cells surround a cancer cell. Credit: NIH

Studying the food poisoning bacteria E. coli may have led scientists to discover a new and improved tool to detect cancer.

In a collaborative research project, scientists from Griffith University's Institute for Glycomics, the University of Adelaide and University of Queensland have detailed their findings in a new paper published in Scientific Reports.

Professor Michael Jennings from the Institute for Glycomics said the E. coli produces a toxin which binds to an unusual sugar that is part of carbohydrate structures present on cells (Neu5Gc) which is not usually produced by .

"The structure that the toxin recognises is known to be a tumour antigen, that is, a substance produced by which are recognised markers for detection and diagnosis."

The research team then took the naturally-occurring toxin and engineered it to change the protein make-up so it became entirely specific to detecting only this singular tumour antigen structure.

"The real innovation here is that we have converted something that was discovered in an infectious disease research program into and were able to utilise it as a tool for potentially detecting tumour antigens," Professor Jennings said.

This tumour antigen is made by a wide range of cancers including breast and ovarian cancer.

"There's a saying in science that chance favours the prepared mind and because at the Institute we work with both infectious diseases and cancer research there was a cross fertilization of ideas and opportunity."

"We were very surprised at how well the engineering of this protein worked and we were able to remove the binding characteristics that were useless in a diagnostic sense and re-engineer it to make it totally specific for the antigen target," he said.

The Neu5Gc is expressed at very high levels on cancer cells but not normal so the discovery of Neu5Gc indicates the patient may be suffering cancer.

Humans are unable to make Neu5Gc but is absorbed into the human body through dietary intake of red meat and dairy.

Professor Jennings said more research has to be done but the important thing is this new tool has the potential to detect far more sensitively, a wide range of possible cancers.

Explore further: Tumor-trained T cells go on patrol

More information: Christopher J. Day et al, Structure aided design of a Neu5Gc specific lectin, Scientific Reports (2017). DOI: 10.1038/s41598-017-01522-9

Related Stories

Tumor-trained T cells go on patrol

May 15, 2017
'Tumour-trained' immune cells - which have the potential to kill cancer cells - have been seen moving from one tumour to another for the first time. The new findings, which were uncovered by scientists at Australia's Garvan ...

Tumour protein could hold key to pancreatic cancer survival

February 23, 2017
A diagnosis of pancreatic cancer is often a death sentence because current chemotherapies have little impact on the disease.

Blood test provides clues to bladder cancer patients' prognoses

February 13, 2017
New research indicates that about one-quarter of patients with bladder cancer treated with radical surgery on curative intent have detectable levels of tumour cells circulating in their blood. The presence of circulating ...

Scientists discover how breast cancer cells spread from blood vessels

February 9, 2016
Researchers have identified a protein that controls how breast cancer cells spread around the body, according to a Cancer Research UK-funded study published in Science Signaling today (Tuesday).

Scientists develop exciting new option for targeted cancer therapy

December 8, 2016
Scientists from Trinity College Dublin have uncovered a new class of compounds - glyconaphthalimides - that can be used to target cancer cells with greater specificity than current options allow.

Recommended for you

Poliovirus therapy induces immune responses against cancer

September 20, 2017
An investigational therapy using modified poliovirus to attack cancer tumors appears to unleash the body's own capacity to fight malignancies by activating an inflammation process that counter's the ability of cancer cells ...

Scientists restore tumor-fighting structure to mutated breast cancer proteins

September 20, 2017
Scientists at the Virginia Tech Carilion Research Institute have successfully determined the full architecture of the breast cancer susceptibility protein (BRCA1) for the first time. This three-dimensional information provides ...

Brain cancer growth halted by absence of protein, study finds

September 20, 2017
The growth of certain aggressive brain tumors can be halted by cutting off their access to a signaling molecule produced by the brain's nerve cells, according to a new study by researchers at the Stanford University School ...

Researchers identify new target, develop new drug for cancer therapies

September 20, 2017
Opening up a new pathway to fight cancer, researchers at the University of Pennsylvania have found a way to target an enzyme that is crucial to tumor growth while also blocking the mechanism that has made past attempts to ...

New clinical trial explores combining immunotherapy and radiation for sarcoma patients

September 20, 2017
University of Maryland School of Medicine researchers are investigating a new approach to treat high-risk soft-tissue sarcomas by combining two immunotherapy drugs with radiation therapy to stimulate the immune system to ...

Targeted antibiotic use may help cure chronic myeloid leukaemia

September 19, 2017
The antibiotic tigecycline, when used in combination with current treatment, may hold the key to eradicating chronic myeloid leukaemia (CML) cells, according to new research.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.